The global intraosseous infusion devices market size is expected to reach USD 1,401.0 million by 2030 and is projected to grow at a CAGR of 6.2% from 2024 to 2030, according to new report by Grand View Research, Inc. The market experiences growth driven by rise in demand for rapid administration of medications or fluids directly into vascular system, surge in number of surgeries, and development of technologically advanced intraosseous infusion devices. In addition, rise in number of emergency cases such as trauma-related attacks and heart attacks is further expected to fuel market growth during the forecast period.

There are numerous sites of intraosseous infusion insertion available such as distal & proximal tibia, sternum, distal femur, and calcaneum. One of the reliable and fastest means of administrating the emergency medication fluids in the sternum is the sternal intraosseous infusion which allow easy vascular access.

Increase in prevalence of cardiovascular diseases, surge in patient and physician awareness of newly launched treatment procedures, significant investments made by government in advanced technologies adopted for rapid and easy administration of medications, fluids or blood products.For instance, According to WHO, cardiovascular diseases cause 17.9 million deaths every year across the globe. In addition, 4 out of 5 cardiovascular disease deaths are caused due to strokes and heart attacks, and around 30% of these deaths occur in the population under 70 years of age.

Launch of advanced intraosseous infusion devices is estimated to boost the market growth during the forecast period. For instance, in June 2023, Teleflex Incorporated received 510(k) U.S. FDA clearance for Arrow EZ-1O IO needle for MR conditional labelling. The EZ-IO needle is a critical component of Arrow EZ-IO intraosseous vascular access system. EZ-1O has a diamond tip for precise, fast, and steady insertion.

Request a free sample copy or view report summary: Intraosseous Infusion Devices Market Report

Intraosseous Infusion Devices Market Report Highlights

• Based on type, the manual IO needles segment led the market with the largest revenue share of 49.4% in 2023. Most generally used manual IO needles are Cardinal Health Illinois /Jamishidi needle, and Cook critical care sur-fast needle, and Cook Dieckman modified needle

• Based on end use, the hospitals & clinics segment led the market with the largest revenue share of 54.9% in 2023. The hospitals & clinics segment is driven by the availability of developed & latest infrastructure, rise in investments to develop sophisticated healthcare infrastructure, and increase in the number of skilled professionals

• North America dominated the market with a revenue share of 41.33% in 2023. The region's advanced healthcare infrastructure, rise in awareness about advanced treatment, and a growing aging population contribute to the market's dominance

• Asia Pacific is estimated to grow at the fastest CAGR during the forecast period, due to the increasing investment in healthcare infrastructure in recent years, particularly in emerging economies such as China and India

Access Press Release @ https://www.grandviewresearch.com/press-release/global-automotive-simulation-software-market

Intraosseous Infusion Devices Market Segmentation

Grand View Research has segmented the global intraosseous infusion devices market report based on type, end-use, and region:

Intraosseous Infusion Devices Type Outlook (Revenue, USD Million, 2018 - 2030)

• Manual IO Needles

• Battery Powered Driver

• Impact Driven Devices

Intraosseous Infusion Devices End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals and Clinics

• Ambulatory Surgical Centers

• Others

Intraosseous Infusion Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Sweden

  • Norway

  • Denmark

• Asia Pacific

  • China

  • Japan

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East and Africa

  • Saudi Arabia

  • South Africa

  • UAE

  • Kuwait

List of Key Companies of the Intraosseous Infusion Devices Market

• Aero Healthcare AU Pty Ltd

• Teleflex Incorporated.

• Becton, Dickinson and Company.

• BIOPSYBELL S.R.L.

• Cook Group

• SAM Medical

• Argon Medical Devices, Inc.

• Cardinal Health, Inc.

• Medax SRL Unipersonle

• StarFish Medical

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.